Publications by authors named "Tejaswini Vukkadala"
Aim: This study aimed to compare the outcomes and efficacy of canalicular trephination with monocanalicular stenting and canaliculodacryocystorhinostomy (canaliculoDCR) with silicone intubation.
Materials And Methods: A prospective comparative study was done in 30 patients (30 eyes) with common canalicular blocks who were randomized into two groups. Fifteen patients underwent canalicular trephination with monocanalicular stenting and 15 patients underwent canaliculoDCR with silicone intubation.
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Indian J Ophthalmol
July 2021
Article Synopsis
- The study focused on COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) in India, examining patient demographics, risk factors, symptoms, and management outcomes during the pandemic's second wave.
- Key findings revealed that 78% of patients had diabetes and a majority required oxygen support; most cases showed ROCM symptoms within 10-15 days post-COVID diagnosis.
- Final outcomes indicated a 14% mortality rate, significantly reduced through surgical interventions, highlighting the role of corticosteroids and diabetes as major contributors to ROCM development.
Dome-shaped macula (DSM) is characterised by a convex anterior bulging of the macular area. It can further get complicated by accumulation of subretinal fluid (SRF). Foveal cysts that are bilateral, in a setting of DSM, are an entity not yet reported.
View Article and Find Full Text PDFAggressive posterior retinopathy of prematurity (APROP) is the most severe form of retinopathy of prematurity (ROP), with rapid progression to tractional retinal detachment. Exudative retinal detachment (ERD) has rarely been described as a primary presentation in ROP. We present a case of unlasered zone 1 APROP in a 34-week infant presenting with bilateral ERD, which was treated with intravitreal ranibizumab.
View Article and Find Full Text PDF